Labshake search

1 - 3 of 3 citations for Norovirus GII.4 VLP since 2019

• Human norovirus infection of primary B cells triggers immune activation in vitro

  Carmen Mirabelli, et al., bioRxiv - Microbiology 2021

  Quote: ... HNoV GII.4 virus-like particles (VLPs) were purchased from The Native Antigen Company, Poly (I:C ...
• Fucoidan but not 2’-Fucosyllactose could inhibit human norovirus replication in zebrafish larvae

  Malcolm Turk Hsern Tan, et al., bioRxiv - Microbiology 2020

  Quote: ... NoV GII.4 VLPs (1.1 mg/ml, purity greater than 95%, The Native Antigen Company, UK) were pre-incubated with the fucoidan (from Fucus vesiculosus ...
• Modulated Zika virus NS1 conjugate offers advantages for accurate detection of Zika virus specific antibody in double antigen binding and Ig capture enzyme immunoassays

  Richard S Tedder, et al., bioRxiv - Microbiology 2019

  Quote: Recombinant DV NS1 antigens (rDVNS1Ag) from the four serotypes (DV 1-4 inclusive) expressed in mammalian cells (The Native Antigen Company, Kidlington, Oxfordshire, OX5 1LH, UK) were used in molar excess as components of the conjugate diluent.